ACI’s Hatch-Waxman Series Advisory Board on “The Three C’s*
Brian Anderson
VP & Assistant General Counsel, IP Litigation
Allergan
Stephanie L. Donahue
Senior Director, Patent Litigation
Sanofi (Bridgewater, NJ)
Hassen A. Sayeed M.D.
Partner
O’Melveny & Myers LLP (New York, NY)
Lisa Jakob
Managing Counsel, Trademark Group
Merck (Rahway, NJ)
Staci Julie
SVP and Chief IP Counsel
Teva Pharmaceuticals (Horsham, PA)
Josephine Liu, Ph.D., J.D.
Head, US IP Litigation
Sandoz Inc. (Princeton, NJ)
John Molenda
Partner
Steptoe & Johnson LLP (New York, NY)
Rekha Hanu, Ph.D, J.D
Executive Director, Chief IP Counsel
Akorn Pharmaceuticals (Lake Forest, IL)
Brian Hirsch
Vice President Global IP and Legal Head North America
Glenmark Pharmaceuticals (Mahwah, NJ)
Jennifer Grant Moitoso
VP, IP
Shire
Pearl T.L. Siew
Senior Vice President and Head, Intellectual Property
Eagle Pharmaceuticals, Inc.
2:00 Cost
Monitoring Legal Spend and Balancing the Budget
- Establishing best practices for cost reduction to enhance predictability for cash flow purposes
- Identifying processes to assist with budgeting, fee arrangements and billing
- Examining the value of licensing deals and structures
2:45 Competency
Finding the Right Talent with Time-Proven Strategies
- Considerations in selecting outside counsel
- Evaluating the appropriateness of work product
- Reconciling firm capabilities versus individual attorney reputation and ability
3:30 Communication
Communicating Value and Collaboration Between Corporate Legal and Outside Counsel
- Establishing the desired level of commitment, availability and responsiveness early-on in the relationship
- Succinctly focusing on shared, pragmatic business goals
- Determining preferences for formality of correspondence and practical versus academic guidance